# Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer

> **NCT00004063** · PHASE1,PHASE2 · UNKNOWN · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 30 (estimated)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** recombinant interferon alfa
- **DRUG:** cisplatin
- **DRUG:** gemcitabine hydrochloride
- **PROCEDURE:** hyperthermia treatment

## Key facts

- **NCT ID:** NCT00004063
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-08
- **Primary completion:** 2011-11
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004063, "Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*